JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shu, Y.
Right arrow Articles by Giacomini, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shu, Y.
Right arrow Articles by Giacomini, K. M.

Vol. 299, Issue 1, 392-398, October 2001

Functional Characteristics and Steroid Hormone-Mediated Regulation of an Organic Cation Transporter in Madin-Darby Canine Kidney Cells

Yan Shu , Carlo L. Bello1 , Lara M. Mangravite, Bo Feng and Kathleen M. Giacomini

Department of Biopharmaceutical Sciences (Y.S., C.L.B., L.M.M., B.F., K.M.G.) and Division of Clinical Pharmacology and Experimental Therapeutics (Y.S., K.M.G.), University of California San Francisco, San Francisco, California

Organic cation transporters (OCT1-3) play an important role in renal elimination of many drugs. The goals of this study were to 1) identify a cell culture model which constitutively expressed OCT2 that could be used to study the characteristics and regulation of this transporter, and 2) to study the mechanisms by which xenobiotics and hormones regulate the activity of OCT2. We characterized the endogenous organic cation transporter (OCT) activity in Madin-Darby canine kidney (MDCK) cells. The activity was localized to the basolateral membrane and was pH and membrane potential-dependent. The uptake of the model organic cation, tetraethylammonium, was saturable (Km, 19.5 ± 4.6 µM; Vmax, 350 ± 19.4 pmol/mg of protein/10 min) and was inhibited by known OCT inhibitors (e.g., cimetidine and quinidine). A cDNA fragment (711 base pairs) isolated by reverse transcriptase-polymerase chain reaction (RT-PCR) was greater than 83% identical to OCT2 cDNAs from mammalian species; no OCT1 or OCT3 was detected by RT-PCR, suggesting that OCT2 may be the primary basolateral OCT in MDCK. OCT2 mRNA levels were increased significantly following exposure of MDCK to the steroid hormones, dexamethasone (2.0-fold), hydrocortisone (2.4-fold), and testosterone (1.8-fold) with comparable increases in activity. Other compounds tested, including the cytochrome P450 inducers, rifampicin, phenobarbital, and phenytoin, and the OCT substrates, verapamil and metformin, had no inducing effects. Collectively, these data indicate that MDCK can serve as a useful and convenient tool in screening candidate drugs for interaction with OCT2 and for studying the regulation of this transporter. Furthermore, our data demonstrate that steroid hormones induce the transcription of OCT2 in the kidney.

1 Current address: Sugen Inc., 230 East Grand Avenue, South San Francisco, CA 94080-4811.

0022-3565/01/2991-0392$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
K. K. Filipski, W. J. Loos, J. Verweij, and A. Sparreboom
Interaction of Cisplatin with the Human Organic Cation Transporter 2
Clin. Cancer Res., June 15, 2008; 14(12): 3875 - 3880.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. M. Pelis, R. C. Hartman, S. H. Wright, T. M. Wunz, and C. E. Groves
Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 555 - 561.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H.-J. Kang, I.-S. Song, H. J. Shin, W.-Y. Kim, C.-H. Lee, J.-C. Shim, H.-H. Zhou, S. S. Lee, and J.-G. Shin
Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population
Drug Metab. Dispos., April 1, 2007; 35(4): 667 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
V. Gorboulev, N. Shatskaya, C. Volk, and H. Koepsell
Subtype-Specific Affinity for Corticosterone of Rat Organic Cation Transporters rOCT1 and rOCT2 Depends on Three Amino Acids within the Substrate Binding Region
Mol. Pharmacol., May 1, 2005; 67(5): 1612 - 1619.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. L. Miakotina, M. Agassandian, L. Shi, D. C. Look, and R. K. Mallampalli
Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2
Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L93 - L102.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. H. Wright and W. H. Dantzler
Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport
Physiol Rev, July 1, 2004; 84(3): 987 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
N. R. Poola, M. Kalis, F. M. Plakogiannis, and D. R. Taft
Characterization of pentamidine excretion in the isolated perfused rat kidney
J. Antimicrob. Chemother., September 1, 2003; 52(3): 397 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
U. Pfeil, K. S. Lips, L. Eberling, V. Grau, R. V. Haberberger, and W. Kummer
Expression of the High-Affinity Choline Transporter, CHT1, in the Rat Trachea
Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 473 - 477.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.